ALX Oncology (ALXO) AGM 2026 summary

Opening remarks and agenda

• CEO welcomed attendees, introduced directors, nominees, and management, and emphasized the benefits of a virtual meeting format.

• Outside counsel, independent auditor, and Inspector of Election were introduced.

• Agenda included election of directors, advisory vote on executive compensation, and ratification of the auditor.

Shareholder proposals

• Stockholders voted on electing three Class III directors to serve until 2029.

• Advisory vote held on executive compensation as disclosed in the proxy statement.

• Ratification of KPMG LLP as independent auditor for fiscal year ending December 31, 2026.

Overview of voting outcomes

• All three director nominees were elected.

• Advisory vote on executive compensation was approved.

• Appointment of KPMG LLP as auditor was ratified.